Market Overview:
This segment is projected to grow at a CAGR of 5.8% from 2018 to 2030 due to increasing demand for PET scans for diagnosis of various types of cancer.
Product Definition:
Nuclear medicine is a medical specialty that uses radioactive materials to diagnose and treat diseases. Physicians who practice nuclear medicine are called radiologists. Nuclear medicines are used to diagnose and treat heart disease, cancer, thyroid problems, and other conditions.
Diagnostic:
The global diagnostic market size was valued at USD 79.6 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The growth can be attributed to factors such as increasing prevalence of chronic diseases, rising demand for early diagnosis, technological advancements, and government initiatives & reforms in healthcare sector across the globe.
Therapeutic:
It also has applications in research for the study of these diseases.
Application Insights:
On the basis of application, the global market has been segmented into oncology, cardiology, thyroid and other diseases and therapeutics. The oncology segment dominated the overall market in terms of revenue share in 2017. Increasing prevalence of cancer across the globe is a major factor contributing to its dominance. According to WHO¢â‚¬â„¢s estimates, around 1 in 6 people dies from cancer globally and this number is expected to increase by about 70 million by 2030 if urgent corrective measures are not taken. This trend is also observed throughout various regions such as Europe where around 250 thousand people die due to cancer every year while another estimation states that there will be about half a million deaths caused by it during next two decades due to lack of early diagnosis and inadequate treatment facilities worldwide.
Regional Analysis:
North America dominated the global market in 2017. Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing government initiatives for improving healthcare infrastructure along with rising patient awareness levels pertaining to availability of advanced treatments such as nuclear medicine in this region. In addition, growing medical tourism industry due to affordability factor will drive demand further.
Growth Factors:
- Increasing demand for nuclear medicine and radiopharmaceuticals due to rising incidence of cancer and other diseases.
- Growing number of PET scans owing to increasing awareness about the benefits of PET scans over traditional imaging techniques.
- Rising demand for targeted therapies and personalized medicines, which is expected to drive the growth of nuclear medicine and radiopharmaceuticals market in the coming years.
- Technological advancements in nuclear medicine and radiopharmaceuticals industry that are helping to improve accuracy, efficiency, and safety of these products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nuclear Medicine & Radiopharmaceuticals Market Research Report
By Type
Diagnostic, Therapeutic
By Application
Oncology, Thyroid, Cardiology, Others
By Companies
China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar, Advanced Molecular-imaging Solution, Shanghai Atom Kexing
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Nuclear Medicine & Radiopharmaceuticals Market Report Segments:
The global Nuclear Medicine & Radiopharmaceuticals market is segmented on the basis of:
Types
Diagnostic, Therapeutic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Thyroid, Cardiology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
- Advanced Molecular-imaging Solution
- Shanghai Atom Kexing
Highlights of The Nuclear Medicine & Radiopharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic
- Therapeutic
- By Application:
- Oncology
- Thyroid
- Cardiology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nuclear Medicine & Radiopharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nuclear medicine and radiopharmaceuticals are medical imaging techniques that use radioactive materials to create images of body tissues or organs. These images can help doctors diagnose and treat diseases.
Some of the major companies in the nuclear medicine & radiopharmaceuticals market are China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar, Advanced Molecular-imaging Solution, Shanghai Atom Kexing.
The nuclear medicine & radiopharmaceuticals market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nuclear Medicine & Radiopharmaceuticals Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nuclear Medicine & Radiopharmaceuticals Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nuclear Medicine & Radiopharmaceuticals Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nuclear Medicine & Radiopharmaceuticals Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nuclear Medicine & Radiopharmaceuticals Market Size & Forecast, 2020-2028
4.5.1 Nuclear Medicine & Radiopharmaceuticals Market Size and Y-o-Y Growth
4.5.2 Nuclear Medicine & Radiopharmaceuticals Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diagnostic
5.2.2 Therapeutic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Thyroid
6.2.3 Cardiology
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nuclear Medicine & Radiopharmaceuticals Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diagnostic
9.6.2 Therapeutic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Thyroid
9.10.3 Cardiology
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diagnostic
10.6.2 Therapeutic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Thyroid
10.10.3 Cardiology
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diagnostic
11.6.2 Therapeutic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Thyroid
11.10.3 Cardiology
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diagnostic
12.6.2 Therapeutic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Thyroid
12.10.3 Cardiology
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diagnostic
13.6.2 Therapeutic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Thyroid
13.10.3 Cardiology
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nuclear Medicine & Radiopharmaceuticals Market: Competitive Dashboard
14.2 Global Nuclear Medicine & Radiopharmaceuticals Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 China Isotope & Radiation
14.3.2 Dongcheng
14.3.3 Jaco
14.3.4 Ciaeriar
14.3.5 Advanced Molecular-imaging Solution
14.3.6 Shanghai Atom Kexing
